Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities

Published:2016-03-30 Issue:2 Volume:9 Page:89-104
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical And Translational Science

Author:

Morrissey KM¹,Yuraszeck TM²,Li C-C¹,Zhang Y²,Kasichayanula S²

Affiliation:

1. Department of Clinical Pharmacology; Genentech Inc; South San Francisco California USA

2. Clinical Pharmacology; Modeling and Simulation, ; Amgen Inc; Thousand Oaks California USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Reference104 articles.

1. Cancer immunotherapy;Couzin-Frankel;Science,2013

2. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study;Bray;Lancet Oncol.

3. Cancer immunoediting from immune surveillance to immune escape;Kim;Immunology,2007

4. Oncology meets immunology: the cancer-immunity cycle;Chen;Immunity,2013

5. Immune escape mechanisms as a guide for cancer immunotherapy;Beatty;Clin. Cancer Res.,2015

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melittin-incorporated nanomedicines for enhanced cancer immunotherapy;Journal of Controlled Release;2024-11

2. Brusatol improves the efficacy of an anti-mouse-PD-1 antibody via inhibiting programmed cell death 1 ligand 1 expression in a murine head and neck squamous cell carcinoma model;Archives of Oral Biology;2024-10

3. Deletion of the RGD motif from the penton base in oncolytic adenoviruses enhances antitumor efficacy of combined CAR T cell therapy;Molecular Therapy: Oncology;2024-09

4. Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells;Cancers;2024-07-07

5. Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E;Clinical Colorectal Cancer;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3